pyridinium 3-methoxyestra-1,3,5(10)-trien-6-yl sulfate (PMTS)

Subscribe to Selected New Research on pyridinium 3-methoxyestra-1,3,5(10)-trien-6-yl sulfate

31 relevant articles (0 outcomes, 5 trials/studies) found for this Bio-Agent

Description: structure given in first source; RN given is for 6alpha isomer

Also Known As:

PMTS; pyridinium 3-methoxyestra-1,3,5(10)-trien-6-yl sulfate, 6beta-isomer

Bio-Agent Context: Research Results

Polycyclic Compounds: 59

Steroids: 14366

Estranes

Estrenes

pyridinium 3-methoxyestra-1,3,5(10)-trien-6-yl sulfate: 31

Heterocyclic Compounds: 25

1-Ring Heterocyclic Compounds

Pyridines: 28

Pyridinium Compounds: 4

pyridinium 3-methoxyestra-1,3,5(10)-trien-6-yl sulfate: 31

Related Diseases

1.	Premenstrual Syndrome (Premenstrual Tension) 12/01/1998 - "METHODS: This study aimed to determine the reliability of using a modified version of the Steiner premenstrual tension self-rating scale (PMTS) questionnaire for assessing retrospectively the presence of premenstrual complaints and to evaluate the association between previous premenstrual complaints and psychiatric symptoms at the time of the menopause. " 01/01/2007 - "Primary efficacy variables were the premenstrual tension scale (PMTS-O) and the clinical global impression of improvement (CGI). " 01/01/1995 - "Symptom scores on the Premenstrual Tension Self-Rating Scale (PMTS), Beck Depression Inventory (BDI), and a Visual Analogue Scale (VAS) were compared for the premenstrual week in the last cycle of treatment. " 06/01/1983 - "The investigation of premenstrual tension syndrome (PMTS) has been hampered by several methodological problems, particularly an inadequate definition of study subjects. " 08/01/1980 - "Research diagnostic criteria for premenstrual tension syndrome (PMTS) are developed using data collected from a study of 42 women who were suffering from severe PMTS but were well at other times. " Order ALL the reference details at left...
2.	Syndrome 06/01/1983 - "The investigation of premenstrual tension syndrome (PMTS) has been hampered by several methodological problems, particularly an inadequate definition of study subjects. " 08/01/1980 - "Research diagnostic criteria for premenstrual tension syndrome (PMTS) are developed using data collected from a study of 42 women who were suffering from severe PMTS but were well at other times. " 06/01/2008 - "The effect on overall PMS symptoms was assessed with the Steiner premenstrual tension syndrome (PMTS) self-rating questionnaire. " 05/01/2005 - "METHODS: Concurrent information from the well-validated Premenstrual Tension Syndrome-Observer (PMTS-O) rating scale was used to evaluate the revised VASs. " 03/01/2002 - "Secondary efficacy measures included scores on the Rating Scale for Premenstrual Tension Syndrome, Clinician-Rated (PMTS-C); the Clinical Global Impression (CGI)-Severity scale; and the Patient Global Impression (PGI)-Improvement scale. " Order ALL the reference details at left...
3.	Neoplasms (Cancer) 05/01/2004 - "In the present study, DMP1 expression in PMTs and other soft tissue tumors was analyzed immunohistochemically to verify its utility in the differential diagnosis of PMTs. " 01/01/2009 - "RESULTS: Primary PMTs constituted 4.8% of the cancer cases in our department. " 01/01/2009 - "PURPOSE: To evaluate the clinical features and treatment results of the primary paravertebral malignant tumors (PMTs) in our department. " 10/01/2006 - "RECENT FINDINGS: A recently developed model of PMTS is presented and applied to the pediatric cancer population. " 05/01/2004 - "DMP1 expression was observed in all of the three cases with PMTs, but never found in other soft tissue tumors examined. " Order ALL the reference details at left...
4.	Tachycardia (Tachyarrhythmias) 11/01/1992 - "Pacemaker mediated tachycardias (PMTs) are a well known complication of P synchronous pacing. " 03/01/1984 - "Programmed single ventricular extrastimulation demonstrated that: (1) merely the presence of VA conduction during EPS, although necessary, was not sufficient to induce PMTs after DDD pacemaker implantation; (2) VPBs introduced late rather than early in the cardiac cycle initiated PMTs in a different way; (3) the initiation of PMTs could be prevented during study by adjusting the programmable parameters (AV delay period, upper rate limit, tachycardia response); (4) one of the two available tachycardia responses of the pulse generator (gradual fall-back response) was able to terminate and initiate PMTs consistently. " 03/01/1984 - "PMTs could be initiated in six of eight patients of Group I and in none of 14 patients of Group II. Initiation and perpetuation of PMTs during DDD pacing were dependent upon the capacity of the patient to conduct ventricular premature beats (VPBs) and subsequent paced ventricular beats retrogradely to the atria, and upon three programmable parameters of the pulse generator (AV delay period, upper rate limit, tachycardia response). " 03/01/1984 - "To evaluate factors playing a role in initiation and perpetuation of pacemaker-mediated tachycardias (PMTs), 22 consecutive patients with symptomatic conduction disorders were studied after implantation of an AV universal (DDD) pulse generator (Cordis 233D). " Order ALL the reference details at left...
5.	Solitary Fibrous Tumors 05/01/2004 - "Three cases with PMTs and 11 other soft tissue tumors (two malignant hemangiopericytomas, three solitary fibrous tumors, three synovial sarcomas, and three malignant peripheral nerve sheath tumors) were analyzed for DMP1 expression. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Dichlorodiphenyldichloroethane (DDD)
2.	Myogenin
3.	Prolactin
4.	Progesterone
5.	Methyltransferases
6.	Lithium
7.	Fatty Acids (Saturated Fatty Acids)
8.	Estrogens (Estrogen)
9.	Calmodulin-Binding Proteins (Caldesmon)
10.	Anticonvulsants (Antiepileptic Drugs)

Related Therapies and Procedures

1.	Palliative Care (Palliative Medicine)
2.	Aftercare (After-Treatment)

Best Treatments:
Research Summary Report
on Premenstrual Syndrome

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 65 Outcomes
Top 200 Key Drugs and Biologics
Top 32 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>